Clinical Trial Recruitment Lab

The Clinical Trial Recruitment Lab (CTRL) pilots, evaluates, and disseminates innovative recruitment strategies to improve access and representation in clinical trials. CTRL’s goal is to coordinate the resources and expertise needed to design and conduct pilots that test real-world solutions, generate evidence, and share best practices to improve recruitment at scale. CTRL brings together stakeholders from academia, industry, and philanthropy to create a collaborative platform for testing innovative strategies in real-world settings.

Program Leadership

Paul Aisen, MD
Director, Alzheimer’s Therapeutic Research Institute

**Phyllis Ferrell, DrPH, MBA**
Nonresident Scholar, USC Schaeffer Institute

**Dana Goldman, PhD**
Founding Director, USC Schaeffer Institute

**Mireille Jacobson, PhD**
Co-Director, Aging and Cognition Program, USC Schaeffer Center

**Desi Peneva, MS**
Research Program Lead, USC Schaeffer Center

**Rema Raman, PhD**
Director, Alzheimer’s Trial Recruitment Innovation Lab

In The News View All

No news items.

Clinical Trial Knowledge Hub

Stronger, more efficient clinical trial recruitment can help accelerate the search for new Alzheimer’s treatments. The Knowledge Hub brings together evidence from our innovative pilots, best practices from the field and insights from leading researchers.

Learn More

Featured White Paper

Key Barriers for Clinical Trials for Alzheimer’s Disease

Alzheimer’s disease (AD) clinical trials are more complicated, costly, and slower than trials for other diseases. Addressing barriers would accelerate the approval of innovative therapies.

Experts: Dana Goldman, Niranjan Bose

Read: Key Barriers for Clinical Trials for Alzheimer’s Disease

Improving the Clinical Trial Ecosystem

CTRL convened leading experts to examine how new technologies are transforming clinical trial recruitment, strategies for overcoming persistent barriers and the value of enabling earlier intervention.

Watch Here

Ongoing Studies

The Alzheimer’s Trial Recruitment Innovation Lab (ATRIL) seeks to diversify participant recruitment and accelerate the process of enrolling a representative population in preclinical and prodromal Alzheimer’s clinical trials through evidence-based science, community engagement and training.

Alzheimer’s Trial Recruitment Innovation Lab

More Clinical Trial Research View All

Evidence Base

Alzheimer’s Biomarkers May Vary Across Populations—Complicating Trial Eligibility

A new study on biomarker variation highlights implications for clinical trial recruitment, access, and participation.

Aging

Featured Experts: Phyllis Barkman Ferrell

News

Experts Highlight How Technology Is Transforming Alzheimer’s Clinical Trial Recruitment

Perspective

Why Widespread Testing for Alzheimer’s Is Essential

White Paper

High-Stakes Medicine: Rethinking Policies for the Cost and Value of Cell and Gene Therapies

In The News View All

WGBH